ABSI - Absci Corp
vs
Region: US
Website: absci.com
Employees: 210
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services
Absci Corporation provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci was founded in 2011 and is headquartered in Vancouver, Washington.
Absci to Participate in Upcoming Investor Conferences
VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Virtual ConferenceFireside chat on Wednesday, April 2 at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time 24th Annual Needham Virtual Healthcare ConferenceFireside ch
Read moreMarch 2025 Penny Stocks Worth Watching
As major U.S. stock indexes edge higher, investors are keenly awaiting the Federal Reserve's latest policy statement and economic forecasts, which could provide insights into future interest rate decisions. While traditional stocks capture much of the spotlight, penny stocks—typically representing smaller or newer companies—continue to offer intriguing opportunities for those willing to explore beyond the usual suspects. Despite being an older term, penny stocks remain a relevant investment...
Read more